Literature DB >> 28856460

Late-onset Pompe disease: a genetic-radiological correlation on cerebral vascular anomalies.

A Pichiecchio1, S Sacco2, P De Filippi3, E Caverzasi4,5, S Ravaglia6, S Bastianello1,7, C Danesino3.   

Abstract

Pompe disease is an autosomal recessive disorder in which deficiency of the lysosomal enzyme acid alpha-glucosidase results in the accumulation of glycogen mostly in muscle tissues. Several reports suggest a higher incidence of intracranial vascular abnormalities (IVAs) in this condition, as well as brain microbleeds and cerebral vasculopathy. The aim of our study was to evaluate through neuroimaging studies the incidence of these anomalies in our cohort of late-onset Pompe disease (LOPD) patients asymptomatic for cerebrovascular disease, looking for correlations with clinical and genetic data. We studied 18 LOPD patients with brain magnetic resonance angiography (MRA), or contrast-enhanced computed tomography (CECT). Diameters of individual arteries were measured and compared with average values as proposed in the literature. We found IVAs in 13 of the 18 patients, mostly dilatative arteriopathy affecting the vertebrobasilar system. The anterior circle was involved in seven of the 18 patients. The diameter of the basilar artery at 1 cm was found to correlate both with age (spearman rho, p = 0.037) and disease duration (p = 0.004), but no other statistically significant correlation was documented. The incidence of intracranial dilatative arteriopathy in LOPD was higher than in the general population, confirming the literature data. However, we did not find intracranial aneurysms microbleeds or significant cerebrovascular disease. Abnormalities in the anterior and the posterior circle of Willis correlated with age and disease duration, but not with the severity of muscle/respiratory involvement or with genetic data. Further studies in larger cohorts of patients are needed to confirm these findings.

Entities:  

Keywords:  Angio-MR; Brain MR; Glycogenosis II; Pompe disease

Mesh:

Substances:

Year:  2017        PMID: 28856460     DOI: 10.1007/s00415-017-8601-1

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  32 in total

1.  Intracranial dilative arteriopathy is associated with chronic kidney disease and small vessel diseases in the elderly.

Authors:  Hiroo Ichikawa; Nobuyoshi Takahashi; Masanori Mukai; Hirotaka Katoh; Tadao Akizawa; Mitsuru Kawamura
Journal:  J Stroke Cerebrovasc Dis       Date:  2009 Nov-Dec       Impact factor: 2.136

2.  High-resolution computed tomography of the basilar artery: 1. Normal size and position.

Authors:  W R Smoker; M J Price; W D Keyes; J J Corbett; L R Gentry
Journal:  AJNR Am J Neuroradiol       Date:  1986 Jan-Feb       Impact factor: 3.825

3.  Long term follow-up of cerebrovascular abnormalities in late onset Pompe disease (LOPD).

Authors:  Matteo Garibaldi; Sabrina Sacconi; Giovanni Antonini; Claude Desnuelle
Journal:  J Neurol       Date:  2017-01-24       Impact factor: 4.849

4.  The pattern of involvement of adult-onset acid maltase deficiency at autopsy.

Authors:  J D van der Walt; M Swash; J Leake; E L Cox
Journal:  Muscle Nerve       Date:  1987 Mar-Apr       Impact factor: 3.217

5.  Basilar artery diameter and 5-year mortality in patients with stroke.

Authors:  Fernando Pico; Julien Labreuche; Isabelle Gourfinkel-An; Pierre Amarenco
Journal:  Stroke       Date:  2006-08-03       Impact factor: 7.914

6.  Aneurysms and vacuolar degeneration of cerebral arteries in late-onset acid maltase deficiency.

Authors:  H A Kretzschmar; H Wagner; G Hübner; A Danek; T N Witt; P Mehraein
Journal:  J Neurol Sci       Date:  1990-09       Impact factor: 3.181

7.  Mutations in the acid alpha-glucosidase gene (M. Pompe) in a patient with an unusual phenotype.

Authors:  J M H Anneser; D E Pongratz; T Podskarbi; Y S Shin; B G H Schoser
Journal:  Neurology       Date:  2005-01-25       Impact factor: 9.910

8.  Thrombotic complications of a basilar artery aneurysm in a young adult with Pompe disease.

Authors:  Daniel Refai; Raisa Lev; Dewitt T Cross; Joshua S Shimony; Jeffery R Leonard
Journal:  Surg Neurol       Date:  2008-01-22

9.  A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease.

Authors:  K Lindpaintner; M A Pfeffer; R Kreutz; M J Stampfer; F Grodstein; F LaMotte; J Buring; C H Hennekens
Journal:  N Engl J Med       Date:  1995-03-16       Impact factor: 91.245

10.  A comparison of CT/CT angiography and MRI/MR angiography for imaging of vertebrobasilar dolichoectasia.

Authors:  A Förster; J Ssozi; M Al-Zghloul; M A Brockmann; H U Kerl; C Groden
Journal:  Clin Neuroradiol       Date:  2013-10-17       Impact factor: 3.649

View more
  6 in total

Review 1.  A Multidisciplinary Perspective Addressing the Diagnostic Challenges of Late-Onset Pompe Disease in the Arabian Peninsula Region Developed From an Expert Group Meeting.

Authors:  Ali Al Shehri; Abdullah Al-Asmi; Abdullah Mohammed Al Salti; Abubaker Almadani; Ali Hassan; Ahmed K Bamaga; Edward J Cupler; Jasem Al-Hashel; Majed M Alabdali; Mohammed H Alanazy; Suzan Noori
Journal:  J Neuromuscul Dis       Date:  2022

2.  Safety of Intradiaphragmatic Delivery of Adeno-Associated Virus-Mediated Alpha-Glucosidase (rAAV1-CMV-hGAA) Gene Therapy in Children Affected by Pompe Disease.

Authors:  Manuela Corti; Cristina Liberati; Barbara K Smith; Lee Ann Lawson; Ibrahim S Tuna; Thomas J Conlon; Kirsten E Coleman; Saleem Islam; Roland W Herzog; David D Fuller; Shelley W Collins; Barry J Byrne
Journal:  Hum Gene Ther Clin Dev       Date:  2017-12       Impact factor: 5.032

3.  Decreased outlet angle of the superior cerebellar artery as indicator for dolichoectasia in late onset Pompe disease.

Authors:  Ole Hensel; Ilka Schneider; Mathias Wieprecht; Torsten Kraya; Stephan Zierz
Journal:  Orphanet J Rare Dis       Date:  2018-04-13       Impact factor: 4.123

4.  Glycogen accumulation in smooth muscle of a Pompe disease mouse model.

Authors:  Angela L McCall; Justin S Dhindsa; Aidan M Bailey; Logan A Pucci; Laura M Strickland; Mai K ElMallah
Journal:  J Smooth Muscle Res       Date:  2021

5.  Is the brain involved in patients with late-onset Pompe disease?

Authors:  Jan J A van den Dorpel; Willemijn M C van der Vlugt; Marjolein H G Dremmen; Ryan Muetzel; Esther van den Berg; Roos Hest; Joni de Kriek; Esther Brusse; Pieter A van Doorn; Ans T van der Ploeg; Johanna M P van den Hout; Nadine A M E van der Beek
Journal:  J Inherit Metab Dis       Date:  2022-01-25       Impact factor: 4.750

6.  Advancements in AAV-mediated Gene Therapy for Pompe Disease.

Authors:  S M Salabarria; J Nair; N Clement; B K Smith; N Raben; D D Fuller; B J Byrne; M Corti
Journal:  J Neuromuscul Dis       Date:  2020
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.